Singh Invited to the NAE 2017 EU-US Frontiers of Engineering Symposium
Prof. Ankur Singh has been selected to attend the National Academy of Engineering (NAE) 2017 EU-US Frontiers of Engineering Symposium (EU-US FOE), which will be hosted by the University of California, Davis, November 16-18. This activity is organized by NAE and the European Council of Applied Sciences, Technologies, and Engineering (Euro-CASE). During the 2.5 days of the symposium, four topics -- Computational Imaging, Next-Generation Solar Cells, Technologies for Space Exploration, and Neuroengineering -- will be covered. The objectives for this bilateral meeting are similar to those for the US Frontiers of Engineering with the added element of facilitating international cooperation and understanding. These include collaborative work, the transfer of new techniques and approaches across fields, and establishment of contacts among the next generation of leaders in engineering. The co-chairs for this event are Dr. Michael Tsapatsis, Professor and Amundson Chair, Department of Chemical Engineering and Materials Science at the University of Minnesota, and Dr. Harri Kulmala, Chief Executive Officer of DIMECC Ltd. The total number of participants at the EU-US FOE symposium will be about 60 engineers, under the age of 45, from European and US industry and universities as well as government labs.
Singh’s research effort centers on creating functional "living" tissues to communicate dynamically with the cell to study and manipulate the cell’s behavior. His laboratory applies engineering principles such as biomaterials engineering, fluid mechanics, tissue and material mechanics, cell engineering, and integrate with fundamental concepts of immunology and pathology. Singh laboratory has developed modular, biomaterials-based organoid technologies that represent 3D immune tissues (e.g. lymph nodes) to study development of healthy and malignant immune cells (lymphomas) in their physio-chemical and mechanical microenvironment, and quantitatively determine predictive power of emerging therapeutics. In addition, his lab is interested in the engineering of micro-nano-scale technologies to develop new cures for cancer, infection, and inflammation. See more details at “Immunotherapy and Cell Engineering Laboratory”